| Year |
Citation |
Score |
| Low-probability matches |
| 2014 |
Kloberg A, Constantinescu R, Nilsson MK, Carlsson ML, Carlsson A, Wahlström J, Haghighi S. Tolerability and efficacy of the monoaminergic stabilizer (-)-OSU6162 (PNU-96391A) in Huntington's disease: a double-blind cross-over study. Acta Neuropsychiatrica. 26: 298-306. PMID 25241758 DOI: 10.1017/neu.2014.16 |
0.08 |
|
| 2012 |
Johansson B, Carlsson A, Carlsson ML, Karlsson M, Nilsson MK, Nordquist-Brandt E, Rönnbäck L. Placebo-controlled cross-over study of the monoaminergic stabiliser (-)-OSU6162 in mental fatigue following stroke or traumatic brain injury. Acta Neuropsychiatrica. 24: 266-74. PMID 25286991 DOI: 10.1111/j.1601-5215.2012.00678.x |
0.08 |
|
| 2012 |
Steensland P, Fredriksson I, Holst S, Feltmann K, Franck J, Schilström B, Carlsson A. The monoamine stabilizer (-)-OSU6162 attenuates voluntary ethanol intake and ethanol-induced dopamine output in nucleus accumbens. Biological Psychiatry. 72: 823-31. PMID 22817867 DOI: 10.1016/j.biopsych.2012.06.018 |
0.08 |
|
| 2011 |
Carlsson ML, Burstein ES, Kloberg A, Hansson S, Schedwin A, Nilsson M, Rung JP, Carlsson A. I. In vivo evidence for partial agonist effects of (-)-OSU6162 and (+)-OSU6162 on 5-HT2A serotonin receptors. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 1511-22. PMID 21874578 DOI: 10.1007/s00702-011-0704-8 |
0.08 |
|
| 2011 |
Burstein ES, Carlsson ML, Owens M, Ma JN, Schiffer HH, Carlsson A, Hacksell U. II. In vitro evidence that (-)-OSU6162 and (+)-OSU6162 produce their behavioral effects through 5-HT2A serotonin and D2 dopamine receptors. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 1523-33. PMID 21866391 DOI: 10.1007/s00702-011-0701-y |
0.08 |
|
| 2011 |
Rung JP, Rung E, Johansson AM, Svensson K, Carlsson A, Carlsson ML. Effects of the dopamine stabilizers (S)-(-)-OSU6162 and ACR16 on prolactin secretion in drug-naive and monoamine-depleted rats. Naunyn-Schmiedeberg's Archives of Pharmacology. 384: 39-45. PMID 21533991 DOI: 10.1007/s00210-011-0641-y |
0.08 |
|
| 2009 |
Gründer G, Hippius H, Carlsson A. The 'atypicality' of antipsychotics: a concept re-examined and re-defined. Nature Reviews. Drug Discovery. 8: 197-202. PMID 19214197 DOI: 10.1038/nrd2806 |
0.08 |
|
| 2008 |
Starck G, Ljungberg M, Nilsson M, Jönsson L, Lundberg S, Ivarsson T, Ribbelin S, Ekholm S, Carlsson A, Forssell-Aronsson E, Carlsson ML. A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 1051-62. PMID 18528631 DOI: 10.1007/s00702-008-0045-4 |
0.08 |
|
| 2008 |
Carlsson A, Carlsson ML. Adaptive properties and heterogeneity of dopamine D(2) receptors - pharmacological implications. Brain Research Reviews. 58: 374-8. PMID 18511124 DOI: 10.1016/j.brainresrev.2007.09.007 |
0.08 |
|
| 2008 |
Rung JP, Rung E, Helgeson L, Johansson AM, Svensson K, Carlsson A, Carlsson ML. Effects of (-)-OSU6162 and ACR16 on motor activity in rats, indicating a unique mechanism of dopaminergic stabilization. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 899-908. PMID 18351286 DOI: 10.1007/s00702-008-0038-3 |
0.08 |
|
| 2006 |
Carlsson A, Carlsson ML. A dopaminergic deficit hypothesis of schizophrenia: the path to discovery. Dialogues in Clinical Neuroscience. 8: 137-42. PMID 16640125 |
0.08 |
|
| 2005 |
Rung JP, Carlsson A, Rydén Markinhuhta K, Carlsson ML. (+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 29: 827-32. PMID 15916843 DOI: 10.1016/j.pnpbp.2005.03.004 |
0.08 |
|
| 2005 |
Rung JP, Carlsson A, Markinhuhta KR, Carlsson ML. The dopaminergic stabilizers (-)-OSU6162 and ACR16 reverse (+)-MK-801-induced social withdrawal in rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 29: 833-9. PMID 15913873 DOI: 10.1016/j.pnpbp.2005.03.003 |
0.08 |
|
| 2004 |
Lundberg S, Carlsson A, Norfeldt P, Carlsson ML. Nicotine treatment of obsessive-compulsive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 28: 1195-9. PMID 15610934 DOI: 10.1016/j.pnpbp.2004.06.014 |
0.08 |
|
| 2004 |
Nilsson M, Carlsson A, Markinhuhta KR, Sonesson C, Pettersson F, Gullme M, Carlsson ML. The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 28: 677-85. PMID 15276693 DOI: 10.1016/j.pnpbp.2004.05.004 |
0.08 |
|
| 2004 |
Nydén A, Carlsson M, Carlsson A, Gillberg C. Interhemispheric transfer in high-functioning children and adolescents with autism spectrum disorders: a controlled pilot study. Developmental Medicine and Child Neurology. 46: 448-54. PMID 15230457 DOI: 10.1017/S001216220400074X |
0.08 |
|
| 2003 |
Grunder G, Carlsson A, Wong DF. Mechanism of new antipsychotic medications: occupancy is not just antagonism. Archives of General Psychiatry. 60: 974-7. PMID 14557141 DOI: 10.1001/archpsyc.60.10.974 |
0.08 |
|
| 2003 |
Gefvert O, Lindström LH, Waters N, Waters S, Carlsson A, Tedroff J. Different corticostriatal patterns of L-DOPA utilization in patients with untreated schizophrenia and patients treated with classical antipsychotics or clozapine. Scandinavian Journal of Psychology. 44: 289-92. PMID 12914593 DOI: 10.1111/1467-9450.00347 |
0.08 |
|
| 2015 |
Khemiri L, Steensland P, Guterstam J, Beck O, Carlsson A, Franck J, Jayaram-Lindström N. The effects of the monoamine stabilizer (-)-OSU6162 on craving in alcohol dependent individuals: A human laboratory study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26482910 DOI: 10.1016/j.euroneuro.2015.09.018 |
0.04 |
|
| 2021 |
Haghighi S, Forsmark S, Zachrisson O, Carlsson A, Nilsson MKL, Carlsson ML, Schuit RC, Gottfries CG. Open-label study with the monoamine stabilizer (-)-OSU6162 in myalgic encephalomyelitis/chronic fatigue syndrome. Brain and Behavior. e02040. PMID 33528911 DOI: 10.1002/brb3.2040 |
0.01 |
|
| 2018 |
Haghighi S, Forsmark S, Carlsson A, Nilsson MKL, Carlsson ML, Schuit RC, Gottfries CG. Open study with (-)-OSU6162 in multiple sclerosis-related fatigue. Acta Neurologica Scandinavica. PMID 30132786 DOI: 10.1111/ane.13007 |
0.01 |
|
| 2017 |
Nilsson MKL, Zachrisson O, Gottfries CG, Matousek M, Peilot B, Forsmark S, Schuit RC, Carlsson ML, Kloberg A, Carlsson A. A randomised controlled trial of the monoaminergic stabiliser (-)-OSU6162 in treatment of myalgic encephalomyelitis/chronic fatigue syndrome. Acta Neuropsychiatrica. 1-10. PMID 29212562 DOI: 10.1017/neu.2017.35 |
0.01 |
|
| 2016 |
Ljungberg M, Nilsson MK, Melin K, Jönsson L, Carlsson A, Carlsson Å, Forssell-Aronsson E, Ivarsson T, Carlsson M, Starck G. 1H magnetic resonance spectroscopy evidence for occipital involvement in treatment-naive paediatric obsessive-compulsive disorder. Acta Neuropsychiatrica. 1-12. PMID 27772535 DOI: 10.1017/neu.2016.52 |
0.01 |
|
| 2015 |
Tolboom N, Berendse HW, Leysen JE, Yaqub M, van Berckel BN, Schuit RC, Ponsen MM, Bakker E, Hoetjes NJ, Windhorst AD, Carlsson ML, Lammertsma AA, Carlsson A. The dopamine stabilizer (-)-OSU6162 occupies a subpopulation of striatal dopamine D2/D3 receptors: an [(11)C]raclopride PET study in healthy human subjects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 472-9. PMID 25248987 DOI: 10.1038/npp.2014.195 |
0.01 |
|
| 1980 |
Carlsson A, Svennerholm L, Winblad B. SEASONAL AND CIRCADIAN MONOAMINE VARIATIONS IN HUMAN BRAINS EXAMINED POST MORTEM. Acta Psychiatrica Scandinavica. 61: 75-85. PMID 28678362 DOI: 10.1111/acps.1980.61.s280.75 |
0.01 |
|
| Hide low-probability matches. |
